New Batches
Brand new clinical-grade molecules or additional batches of existing ones, added recently to the in-stock potfolio
Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecules
Isotypes
Expiry Date
CoA
Filters
Sort results
Reset
Apply
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
2025.02 |
1.296,00 € |
||
EGFR , MET |
Bispecific Antibody |
Rybrevant® |
50 mg/ml |
– |
7 mg |
-80°C |
2027.04 |
376,00 € |
||
CD19 , CD3 |
Bispecific Antibody |
Blincyto® |
0,0125 mg/mL |
– |
0,002 mg |
-80°C |
2027.07 |
1.051,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
2 mg |
-80°C |
2027.09 |
1.006,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2025.03 |
274,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
5 mg |
-80°C |
2027.07 |
319,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2025.07 |
493,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2025.10 |
1.396,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2025.10 |
1.149,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2026.03 |
2.394,00 € |
||
Fc Receptor (FcRn) |
Antibody Fab'fragment |
Vyvgart® |
20 mg/mL |
– |
5 mg |
-80 °C |
2024.04 |
808,00 € |
||
Nect |
Antibody-drug conjugate (ADC) |
Padcev® |
10 mg/mL |
– |
1 mg |
-80 °C |
2026.08 |
385,00 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
2025.03 |
615,00 € |
||
IL13 |
Monoclonal Antibody |
Ebglyss® |
125 mg/mL |
– |
20 mg |
-80°C |
2026.05 |
607,00 € |
||
CD19 |
Antibody-drug conjugate (ADC) |
Zynlonta® |
5 mg/mL |
– |
0,5 mg |
tba |
tba |
2.474,00 € |
||
Tubulin |
Nanoparticle |
Abraxane® |
5 mg/mL |
– |
5 mg |
-80°C |
2026.02 |
355,00 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
4 mg |
-80°C |
2026.04 |
202,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Rixathon® |
10 mg/mL |
– |
2 mg |
-80 °C |
2026.03 |
320,00 € |
||
B cell maturation antigen , CD3 |
Bispecific Antibody |
Tecvayli® |
10 mg/mL |
– |
1 mg |
-80°C |
2024.10 |
410,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Kanjinti® |
21 mg/mL |
– |
6 mg |
-80°C |
2025.01 |
367,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Zercepac® |
21 mg/mL |
– |
6 mg |
-80°C |
2026.08 |
367,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ogivri® |
21 mg/mL |
– |
6 mg |
-80°C |
2025.10 |
451,00 € |
Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products
aliquoted from medicines
-
Which molecule(s)
are you looking for?